PRESS-RELEASE ·Filed Sep 23, 2026
Press release · Announcement
Actionable Insight • Neutral
Monitor upcoming quarterly results for any mention of EVOS PELVIC adoption or revenue contribution, but this launch alone is unlikely to move the stock.
Latest settled — T+20d ⚠ clustered
SNN ▲ +8.99% at T+20d
NEUTRAL call +8.99% · α vs SPY +8.30% · entry $26.82 → $29.23
Latest observation: T+22 +16.84% FF3 residual α
T+1d
-0.52%
call -0.52% · α -0.44%
$26.68
settled 5w ago
T+5d
+0.52%
call +0.52% · α +1.20%
$26.96
settled 27d ago
T+20d
+8.99%
call +8.99% · α +8.30%
$29.23
settled 6d ago
T+60d
Pending
in 7w
Price Chart
Loading chart...
Executive Summary
Smith+Nephew launched the EVOS PELVIC Plating System, a new product in its trauma plating portfolio for pelvic and acetabular surgery. The launch is a routine product expansion with no financial terms disclosed, making it a neutral event for the stock.
Key Facts
- EVOS PELVIC Plating System launched for pelvic and acetabular fracture surgery.
- System includes pre-contoured plates, cannulated screws, and specialized instrumentation.
- Available in the United States; other market availability varies.
- Will be previewed at the 2026 OTA Annual Meeting in Nashville, TN (Sept 23-26).
- No financial terms, revenue guidance, or sales projections disclosed.
Financial Impact
No financial impact disclosed; product launch is incremental to existing EVOS platform.
Risk Factors
- Competitive response from other trauma device makers (e.g., Stryker, DePuy Synthes).
- Adoption rate may be slower than expected if surgeons prefer existing systems.
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3367719 |
38 reports for SNN
63% Hit rate @ T+5 Went positive at some point 7 of 8 best @ T+20▲ +8.02%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 6-K | $30.88 | awaiting T+5 | — | $30.47 (−1.33%) |
Oct 8, 2026 18d ago | 6-K | $26.96 $29.09 | ▲ +7.90% | ▲ +8.18% | $30.47 (+13.02%) |
Oct 1, 2026 25d ago | 6-K | $26.58 $26.96 | ▲ +1.43% | ▲ +0.13% | $30.47 (+14.64%) |
Oct 1, 2026 25d ago | 6-K | $26.58 $26.96 | ▲ +1.43% | ▲ +0.13% | $30.47 (+14.64%) |
Sep 23, 2026 4w ago | Press Release | $26.82 $26.96 | ▲ +0.52% | ▲ +1.20% | $30.47 (+13.61%) |
Sep 23, 2026 4w ago | Press Release | $26.82 $26.96 | ▲ +0.52% | ▲ +1.20% | $30.47 (+13.61%) |
Sep 18, 2026 5w ago | 6-K | $27.56 $26.91 | ▼ −2.36% | ▼ −3.63% | $30.47 (+10.56%) |
Sep 18, 2026 5w ago | 6-K | $27.56 $26.91 | ▼ −2.36% | ▼ −3.63% | $30.47 (+10.56%) |
Sep 16, 2026 5w ago | 6-K | $27.80 $26.82 | ▼ −3.53% | ▼ −6.09% | $30.47 (+9.60%) |
Sep 16, 2026 5w ago | 6-K | $27.80 $26.82 | ▼ −3.53% | ▼ −6.09% | $30.47 (+9.60%) |
Showing 10 of 38
US Market Status
Market Closed — Opens in 8h 16m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers